The PE Ratio as of December 2024 (TTM) for 180 Life Sciences Corp. (ATNF) is 0.24

According to 180 Life Sciences Corp.’s latest financial reports and current stock price. The company's current PE Ratio is 0.24. This represents a change of -96.56% compared to the average of 6.98 of the last 4 quarters.

180 Life Sciences Corp. (ATNF) Historical PE Ratio (quarterly & annually)

How has ATNF PE Ratio performed in the past?

The mean historical PE Ratio of 180 Life Sciences Corp. over the last ten years is 11.01. The current 0.24 PE Ratio has changed 118.01% with respect to the historical average. Over the past ten years (40 quarters), ATNF's PE Ratio was at its highest in in the June 2017 quarter at 626.93. The PE Ratio was at its lowest in in the June 2019 quarter at -241.04.

180 Life Sciences Corp. (ATNF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of 180 Life Sciences Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

180 Life Sciences Corp. (ATNF) Average PE Ratio

How has ATNF PE Ratio performed in the past?

The current PE Ratio of 180 Life Sciences Corp. (ATNF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

180 Life Sciences Corp. (ATNF) PE Ratio vs. Peers

How is ATNF’s PE Ratio compared to its peers?

180 Life Sciences Corp.’s PE Ratio is greater than Zura Bio Limited (-4.90), greater than Phio Pharmaceuticals Corp. (-0.28), greater than Sonnet BioTherapeutics Holdings, Inc. (-0.18), greater than Cardio Diagnostics Holdings, Inc. (-2.99), greater than Altamira Therapeutics Ltd. (-0.02), greater than Immix Biopharma, Inc. (-2.97), greater than Enveric Biosciences, Inc. (-0.28), greater than Palisade Bio, Inc. (-0.19), greater than CNS Pharmaceuticals, Inc. (-0.14), greater than eFFECTOR Therapeutics, Inc. (-0.00), greater than Navidea Biopharmaceuticals, Inc. (0.00), greater than ZyVersa Therapeutics, Inc. (-0.00), greater than Apexigen, Inc. (-0.24),

Build a custom stock screener for 180 Life Sciences Corp. (ATNF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like 180 Life Sciences Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

180 Life Sciences Corp. (ATNF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like 180 Life Sciences Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.